Medical Scientist Training Program (MSTP)
Forecast
National Institutes of Health plans to offer grants to nonprofits, colleges and universities and tribes. It is a forecast: the notice is expected around March 16, 2027, with applications due around May 25, 2027.
From the official notice on Grants.gov, last changed February 10, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awardsnot stated
- Total fundingnot stated
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | February 10, 2026 |
|---|---|
| Expected posting | March 16, 2027 |
| Expected deadline | May 25, 2027 |
| Expected award date | April 1, 2028 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities and tribes.
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible ApplicantsEligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In alignment with the goal of the NRSA program, the Medical Scientist Training Program (MSTP) supports the development of well-trained clinician-scientist leaders to address the nation’s biomedical research needs. MSTP will support eligible, domestic organizations to develop and implement effective, evidence-informed approaches to dual-degree training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise and lead to the completion of both a clinical degree (for example, M.D., D.O., D.V.M., D.D.S., Pharm.D., etc.) and a research doctorate degree (Ph.D.). MSTP incorporates didactic, research, mentoring, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the nation.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to NIGMS MSTP T32, nigmsmstpt32@nigms.nih.gov, Please contact via e-mail.
Questions people ask
Who can apply for Medical Scientist Training Program (MSTP)?
National Institutes of Health accepts applications from nonprofits, colleges and universities and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Medical Scientist Training Program (MSTP)?
Expected deadline May 25, 2027. Confirm the date and time in the official notice on Grants.gov.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience